Medicine and Dentistry
Adjuvant
11%
Alkylating Antineoplastic Agent
5%
Blood Brain Barrier
11%
Cancer Incidence
11%
Cancer Model
5%
Cancer Research
100%
CDK4/6 Inhibitor
5%
Chemoradiotherapy
11%
Clinical Research
11%
Clinical Trial
5%
Clinician
22%
Combination Therapy
5%
Cyclin Dependent Kinase Inhibitor 2A
5%
Cyclin-Dependent Kinase
5%
Disease Exacerbation
11%
Disease Resistance
11%
Diseases
22%
Drug Response
5%
Drug Screening
11%
Epidermal Growth Factor Receptor
16%
Ganglioglioma
100%
Gene Mutation
11%
Glioblastoma
94%
Health Care Cost
11%
Intracranial Tumor
88%
Malignant Neoplasm
88%
Methylation
11%
Microglia
11%
Molecular Profiling
11%
Neoplasm
88%
Nervous System Tumor
11%
Next Generation Sequencing
11%
Organoid
88%
Parenchyma
11%
Personalized Medicine
5%
Primary Tumor
5%
Promoter Region
16%
Proteomics
11%
Signal Transduction Pathway
11%
Somatics
11%
Systems Medicine
88%
Tamsulosin
88%
Targeted Therapy
5%
Temozolomide
22%
Transcriptomics
5%
Translational Research
5%
Tumor Biology
16%
Tumor Recurrence
5%
Vascularity
5%
Xenograft
88%
Keyphrases
Adjuvant Radiochemotherapy
11%
Advisory Board
5%
Aggressive Treatment
5%
Astrocytic Tumor
5%
Bifunctional Alkylating Agent
7%
Blood-brain Barrier
5%
Brain Parenchyma
5%
Brain Systems
5%
Brain Tumor
44%
Cancer Systems
44%
Cell Clones
5%
Clinical Datasets
5%
Clinical Research Data
11%
Clonal Evolution
5%
Computational Modeling
5%
Computational System
5%
Curative Treatment
5%
Cyclin-dependent Kinase 4 (CDK4)
14%
Data Integration
5%
Disease Progression
5%
Disease Resistance Mechanism
11%
Disease Subtypes
22%
Drug Development
5%
Drug Testing
14%
Early-stage Researchers
11%
Economic Burden
5%
European Healthcare
5%
European Research
44%
Female Model
11%
Gender Analysis
5%
Gene mutation
5%
Genome Analysis
5%
Genomics-proteomics
5%
Glial Cells
5%
Glioblastoma
44%
Grade IV Glioma
11%
Health Avatar
44%
Healthcare Sector
5%
High-throughput Drug Screen
7%
IDH-mutant Glioma
44%
Improved Patient Outcomes
11%
Initial Performance
5%
Innovative Research
5%
Innovative System
11%
Innovative Therapies
5%
Integrative multi-omics
88%
Interdisciplinary Research
5%
International Academics
11%
Intersectoral Research
11%
Long-range Propagation
7%
Long-term Survivors
5%
Male Models
11%
Malignant Cells
5%
Mechanistic Understanding
5%
MGMT Promoter Methylation
5%
Molecular Analysis
5%
Molecular Profiling
5%
Multi-omics
22%
Multiple Signals
5%
Nervous System Tumors
5%
Next-generation Sequencing Technology
5%
Novel Therapeutics
5%
Omics Data
5%
Omics Technologies
5%
Ongoing Trials
22%
Organoid Culture
14%
Orthotopic Xenograft
44%
Pathway-specific
5%
Patient-derived Organoids
44%
Performance Status
5%
Personalized Treatment
7%
Preclinical Tool
14%
Prefetcher
22%
Primary Malignancy
22%
Resistant Cells
5%
Signal Transduction Pathway
5%
Single-cell Technologies
22%
Specific Genes
5%
Stratagem
22%
Surgical Adjuvants
11%
Surgical Removal
5%
Surgical Resection
5%
System-level Analysis
5%
Systemic Agents
11%
Systems Biology
5%
Systems Medicine
44%
Technological Approaches
22%
Temozolomide
5%
Therapeutic Strategies
5%
Transcriptomic Adaptation
7%
Treatment Costs
5%
Treatment Resistance
5%
Treatment Standards
5%
Treatment-resistant
5%
Tumor
16%
Tumor Biology
5%
Tumor Incidence
5%
Tumor Organoids
14%
Tumor Research
44%
Unmet Needs
5%
WHO Grade IV
5%
Young Female Patient
11%
Biochemistry, Genetics and Molecular Biology
Alpha Thalassemia/Mental Retardation X-Linked
14%
Antigen Presentation
7%
Blood Brain Barrier
29%
Cancer Incidence
29%
Cancer Model
14%
Cell Clone
29%
Cell Level
7%
Clinical Research
29%
Clinical Trial
14%
Clonal Evolution
44%
Copurification
7%
Cryopreservation
7%
Cyclin Dependent Kinase Inhibitor 2A
14%
Cyclin-Dependent Kinase
14%
Drug Response
14%
Drug Screening
44%
Epidermal Growth Factor Receptor
44%
Epigenetics
14%
Gene Mutation
29%
Genetics
29%
Genomics
59%
Glial Cells
29%
IDH1
29%
In Vivo Study
29%
Macrophage
7%
Methylation
29%
Microglia
59%
Myeloid
7%
Next Generation Sequencing
29%
Phagocytosis
7%
Phenotypic Plasticity
14%
Platelet Derived Growth Factor Receptor Alpha
14%
Promoter Region
44%
Proteomics
29%
RNA Sequence
44%
RNA Sequencing
7%
Signal Transduction
29%
Tamsulosin
88%
Transcriptomics
59%
Tumor Escape
7%
Vascularization
14%